U.S. markets close in 2 hours 27 minutes
  • S&P 500

    3,445.58
    +2.46 (+0.07%)
     
  • Dow 30

    28,272.94
    -35.85 (-0.13%)
     
  • Nasdaq

    11,523.76
    +7.27 (+0.06%)
     
  • Russell 2000

    1,608.34
    -9.36 (-0.58%)
     
  • Crude Oil

    39.92
    -1.78 (-4.27%)
     
  • Gold

    1,928.20
    +12.80 (+0.67%)
     
  • Silver

    25.25
    +0.27 (+1.08%)
     
  • EUR/USD

    1.1874
    +0.0045 (+0.38%)
     
  • 10-Yr Bond

    0.8040
    +0.0070 (+0.88%)
     
  • GBP/USD

    1.3156
    +0.0209 (+1.62%)
     
  • USD/JPY

    104.5000
    -0.9700 (-0.92%)
     
  • BTC-USD

    12,824.29
    +1,767.28 (+15.98%)
     
  • CMC Crypto 200

    257.07
    +12.18 (+4.97%)
     
  • FTSE 100

    5,776.50
    -112.72 (-1.91%)
     
  • Nikkei 225

    23,639.46
    +72.42 (+0.31%)
     

Are You Looking for a High-Growth Dividend Stock? Merck (MRK) Could Be a Great Choice

Zacks Equity Research
·3 mins read

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its dividend yield, a metric that measures a dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Merck in Focus

Merck (MRK) is headquartered in Kenilworth, and is in the Medical sector. The stock has seen a price change of -6.25% since the start of the year. Currently paying a dividend of $0.61 per share, the company has a dividend yield of 2.86%. In comparison, the Large Cap Pharmaceuticals industry's yield is 2.33%, while the S&P 500's yield is 1.65%.

In terms of dividend growth, the company's current annualized dividend of $2.44 is up 8% from last year. Merck has increased its dividend 5 times on a year-over-year basis over the last 5 years for an average annual increase of 6.77%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Merck's current payout ratio is 44%. This means it paid out 44% of its trailing 12-month EPS as dividend.

MRK is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2020 is $5.70 per share, which represents a year-over-year growth rate of 9.83%.

Bottom Line

Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. However, not all companies offer a quarterly payout.

For instance, it's a rare occurrence when a tech start-up or big growth business offers their shareholders a dividend. It's more common to see larger companies with more established profits give out dividends. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. That said, they can take comfort from the fact that MRK is not only an attractive dividend play, but is also a compelling investment opportunity with a Zacks Rank of #2 (Buy).


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Merck Co., Inc. (MRK) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research